Cambridge Investment Research Advisors’s Innovator US Equity 10 Buffer ETF Quarterly ZALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
35,090
+6,765
+24% +$227K ﹤0.01% 2144
2026
Q1
$919K Sell
28,325
-1,915
-6% -$62.6K ﹤0.01% 2244
2025
Q4
$985K Buy
30,240
+8,377
+38% +$270K ﹤0.01% 2106
2025
Q3
$697K Buy
21,863
+2,572
+13% +$80.8K ﹤0.01% 2358
2025
Q2
$594K Sell
19,291
-313
-2% -$9.4K ﹤0.01% 2389
2025
Q1
$584K Buy
+19,604
New +$588K ﹤0.01% 2283

Other funds holding ZALT

Cambridge Investment Research Advisors's ZALT Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Innovator US Equity 10 Buffer ETF Quarterly (ZALT) stake by 24% in Q2 2026, buying an estimated $227K and bringing the position to 35,090 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2144.

Cambridge Investment Research Advisors first reported a position in ZALT in Q1 2025 and has held it in 6 quarters since. 104 funds tracked by Wall St. Rank hold ZALT as of Q2 2026.

  • Cambridge Investment Research Advisors held 35,090 shares of Innovator US Equity 10 Buffer ETF Quarterly worth $1.19M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 6,765 Innovator US Equity 10 Buffer ETF Quarterly shares in Q2 2026, an estimated $227K.
  • Innovator US Equity 10 Buffer ETF Quarterly made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2144 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator US Equity 10 Buffer ETF Quarterly in Q1 2025 and has held it in 6 quarters since.
  • 104 funds tracked by Wall St. Rank held Innovator US Equity 10 Buffer ETF Quarterly as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.